Paperpal Prime Logo

JTO Clinical and Research Reports : Impact Factor & More

eISSN: 2666-3643
JournalOpen Access

Key Metrics

CiteScore
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JTO Clinical and Research Reports

JTO Clinical and Research Reports Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Article Processing ChargesUSD 2000
Publication Time19
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Association for the Study of Lung Cancer
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in JTO Clinical and Research Reports ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JTO Clinical and Research Reports

Toward Global Integration of Exercise in Lung Cancer Care: The IREX-Lung Initiative
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis.
  • 1 Nov 2026
  • JTO clinical and research reports
High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study.
  • 1 Nov 2026
  • JTO clinical and research reports
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Toward Global Integration of Exercise in Lung Cancer Care: The IREX-Lung Initiative
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis.
  • 1 Nov 2026
  • JTO clinical and research reports
High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study.
  • 1 Nov 2026
  • JTO clinical and research reports
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
  • 1 Nov 2026
  • JTO Clinical and Research Reports
Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
  • 1 Nov 2026
  • JTO Clinical and Research Reports

FAQs on JTO Clinical and Research Reports